- Who can participate: Adults aged 18 to 65 with a diagnosis of chronic pain for at least six months are eligible. Participants must not have any serious underlying health conditions and should not be currently enrolled in another clinical trial.
- Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. The placebo is an inactive substance designed to mimic the investigational medication for comparison purposes. Participants will be required to take the study medication daily and attend regular check-ups.